Skip to Main Content

Paper Details

Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.
Clin Cancer Res
12
2023
Bevacizumab, Denifanstat, FASN, Glioblastoma, High-Grade Astrocytoma, Patients, TVB-2640, astrocytoma, bevacizumab, dry eye, fatigue, fatty acid, fatty acid synthase, high-grade astrocytoma, hypertension, mucositis, palmar-plantar erythrodysesthesia, patients, primary brain tumor, skin infection
Author NameAffiliation
Joel E MichalekMays Cancer Center, University of Texas Health Science Center at San Antonio
Joel E MichalekMays Cancer Center, University of Texas Health Science Center at San Antonio
Yidong ChenMays Cancer Center, University of Texas Health Science Center at San Antonio
  • 1 - 3

Datasets

Release 1.2